Back to results
US 5,968,976 AGranted
Pharmaceutical composition containing selected lanthanum carbonate hydrates
AssigneeAnorMED, Inc.
InventorsBarry A Murrer, Nigel A Powell
Life of this patent
Estimating the term…
Abstract
Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.
Claims10
A pharmaceutical composition for the treatment of hyperphosphataemia comprising lanthanum carbonate of the formula
- La.sub.2 (CO.sub.3).sub.3.xH.sub.2 O
- where x has a value from 3 to 6, in admixture with a pharmaceutically acceptable diluent or carrier in a form for administration to the gastrointestinal tract.
A method to treat hyperphosphataemia in a subject which method comprises administering to said subject an amount of lanthanum carbonate of the formula
- La.sub.2 (CO.sub.3).sub.3.xH.sub.2 O
- wherein x has a value from 3 to 6 effective to treat said hyperphosphataemia.
Dependencies are inferred from the claim text.